Boon A J, Tans J T, Delwel E J, Egeler-Peerdeman S M, Hanlo P W, Wurzer H A, Hermans J
Department of Neurology, Westeinde Hospital, The Hague, The Netherlands.
Surg Neurol. 2000 Mar;53(3):201-7. doi: 10.1016/s0090-3019(00)00182-8.
Comparison of the predictive value of four "diagnostic tests" for the outcome of shunting in patients with normal-pressure hydrocephalus (NPH).
Ninety-five NPH patients who received shunts were followed for 1 year. Gait disturbance and dementia were quantified by an NPH scale and handicap by a modified Rankin scale. Primary outcome measures were differences between the preoperative and last scores on both the NPH scale and the modified Rankin scale. Clinical and computed tomographic (CT) findings typical of NPH, absence of cerebrovascular disease, and a resistance to outflow of cerebrospinal fluid (CSF) >/= 18 mmHg/ml/minute were designated as a positive test outcome; clinical and CT findings compatible with NPH, presence of cerebrovascular disease, and an outflow resistance < 18 mmHg/ml/minute as a negative test outcome.
For each of the four tests the percentage of patients classified as improved was significantly greater for those with positive than with negative test results. Measurement of CSF outflow resistance was the only significant prognostic factor for the improvement ratio in NPH scale and CT in the modified Rankin scale according to multivariate logistic regression analysis. The accurate predictive value of the combination of typical clinical and CT findings was 0.65, that of the positive test results of outflow resistance, clinical and CT findings was 0.74.
The best strategy is to shunt NPH patients if their outflow resistance is >/= 18 mmHg/ml/minute or, when the outflow resistance is lower, if their clinical as well as their CT findings are typical of NPH.
比较四种“诊断试验”对正常压力脑积水(NPH)患者分流结果的预测价值。
对95例接受分流术的NPH患者进行了1年的随访。步态障碍和痴呆通过NPH量表进行量化,残疾程度通过改良Rankin量表进行评估。主要结局指标是NPH量表和改良Rankin量表术前和末次评分之间的差异。典型的NPH临床和计算机断层扫描(CT)表现、无脑血管疾病以及脑脊液(CSF)流出阻力≥18 mmHg/ml/分钟被指定为试验阳性结果;与NPH相符的临床和CT表现、存在脑血管疾病以及流出阻力<18 mmHg/ml/分钟被指定为试验阴性结果。
对于这四种试验中的每一种,试验结果为阳性的患者中分类为病情改善的百分比显著高于试验结果为阴性的患者。根据多因素逻辑回归分析,脑脊液流出阻力的测量是NPH量表改善率和改良Rankin量表中CT改善率的唯一显著预后因素。典型临床和CT表现组合的准确预测价值为0.65,流出阻力、临床和CT表现的阳性试验结果的准确预测价值为0.74。
最佳策略是,如果NPH患者的流出阻力≥18 mmHg/ml/分钟,或者当流出阻力较低时,如果其临床和CT表现为典型的NPH,则对其进行分流。